In terms of pathway analysis, HCC patients with subtype 1 were predominantly associated with “KRAS_SIGNALING_DN”, “COAGULATION”, “regulation of inflammatory response”, and “immune response-activating cell surface receptor signaling pathway” (Fig. 3A–D). This evidence concerns the gene CD177 and hepatocellular carcinoma.